Floatz logo

TENOFOVIR DISOPROXIL FUMARATE

Hypertriglyceridemia

National Institute of Allergy and Infectious Diseases (NIAID)Small moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Hypertriglyceridemia cohort.

Asset / SponsorPhaseRating
Amprenavir
Felizarta, Franco, M.D.
Phase 4BB
Fenofibrate
Abbott
Phase 4BB
Saffron
Birjand University of Medical Sciences
Phase 4BB
Lipitor
The University of Western Australia
Phase 4BB
RITONAVIR
Felizarta, Franco, M.D.
Phase 4BB

View all 27 →

Same molecule, other indications

TENOFOVIR DISOPROXIL FUMARATE is also rated in:

chronic hepatitis B virus infectionDormant
BBB
Indicative ·
72 / 100
View asset →
HIV infectious diseaseDormant
BBB
Indicative ·
72 / 100
View asset →
lipodystrophyDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →